Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: CNS Drugs. 2014 Jan;28(1):79–88. doi: 10.1007/s40263-013-0120-8

Table 1b.

Baseline characteristics of patients with depression, ages 25–64 years, initiating antidepressant therapy before and after propensity score matching on the probability of receiving SNRI therapy

Pre-Matched Cohort Propensity Score Matched Cohort
Characteristic SSRI
N=225,952
SNRI
N=36,037
SSRI
N=72,028
SNRI
N=36,037
Age
 25–40 93,806 (41.5%) 13,227 (36.7%) 26,992 (37.5%) 13,227 (36.7%)
 41–55 96,389 (42.7%) 16,712 (46.4%) 32,307 (44.9%) 16,712 (46.4%)
 56+ 35,757 (15.8%) 6,098 (16.9%) 12,729 (17.7%) 6,098 (16.9%)
Sex, M 74,212 (32.8%) 11,202 (31.1%) 23,001 (31.9%) 11,202 (31.1%)
Severity Level of Depression Diagnosis
 T1: Primary Inpatient diagnosis <=30 Days Pre-Index Date 2,150 (1.0%) 450 (1.2%) 928 (1.3%) 450 (1.2%)
 T2: Primary Inpatient diagnosis 31–360 Days Pre-Index Date 406 (0.2%) 142 (0.4%) 235 (0.3%) 142 (0.4%)
 T3: Non-Primary Inpatient diagnosis <=360 Days Pre-Index Date 5,518 (2.4%) 1,064 (3.0%) 2,016 (2.8%) 1,064 (3.0%)
 T4: 2+ Outpatient Diagnosis <=360 Days Pre-Index Date 116,171 (51.4%) 20,737 (57.5%) 37,969 (52.7%) 20,737 (57.5%)
 T5: 1 Outpatient Diagnosis <=360 Days Pre-Index Date 101,707 (45.0%) 13,644 (37.9%) 30,880 (42.9%) 13,644 (37.9%)
Anxiety Disorders 54,993 (24.3%) 9,402 (26.1%) 19,517 (27.1%) 9,402 (26.1%)
Baseline DSH 519 (0.2%) 93 (0.3%) 185 (0.3%) 93 (0.3%)
Primary Inpatient Depression Diagnosis 2,556 (1.1%) 592 (1.6%) 1,163 (1.6%) 592 (1.6%)
No Depression Diagnosis w/in 3 0 Days of Index Date 45,707 (20.2%) 10,522 (29.2%) 21,068 (29.2%) 10,522 (29.2%)
Baseline Suicidal Ideation (2006–2010 only) 1,103 (0.8%) 218 (0.9%) 463 (1.0%) 218 (0.9%)
Cognitive Impairment/Dementia 242 (0.1%) 47 (0.1%) 95 (0.1%) 47 (0.1%)
Personality Disorder 1,269 (0.6%) 257 (0.7%) 554 (0.8%) 257 (0.7%)
Substance Abuse 20,334 (9.0%) 3,630 (10.1%) 7,853 (10.9%) 3,630 (10.1%)
Use of Any Opiate 72,807 (32.2%) 13,668 (37.9%) 27,456 (38.1%) 13,668 (37.9%)
Number of Distinct Drug Prescriptions Filled
 1 (Antidepressant Only) 21,005 (9.3%) 3,229 (9.0%) 6,213 (8.6%) 3,229 (9.0%)
 2–3 51,943 (23.0%) 7,321 (20.3%) 14,564 (20.2%) 7,321 (20.3%)
 4–5 46,441 (20.6%) 6,688 (18.6%) 12,834 (17.8%) 6,688 (18.6%)
 6–9 60,524 (26.8%) 9,556 (26.5%) 19,454 (27.0%) 9,556 (26.5%)
 10+ 46,039 (20.4%) 9,243 (25.6%) 18,963 (26.3%) 9,243 (25.6%)
Number of Psychiatric Hospitalizations, 1+ 2,694 (1.2%) 608 (1.7%) 1,197 (1.7%) 608 (1.7%)
Number of Outpatient Visits
 <5 39,311 (17.4%) 4,966 (13.8%) 9,338 (13.0%) 4,966 (13.8%)
 5–9 54,399 (24.1%) 7,671 (21.3%) 15,001 (20.8%) 7,671 (21.3%)
 10–19 67,688 (30.0%) 10,581 (29.4%) 21,639 (30.0%) 10,581 (29.4%)
 20–39 46,533 (20.6%) 8,436 (23.4%) 17,357 (24.1%) 8,436 (23.4%)
 40+ 18,021 (8.0%) 4,383 (12.2%) 8,693 (12.1%) 4,383 (12.2%)
Number of Hospitalizations for Substance Abuse, 1+ 1,192 (0.5%) 241 (0.7%) 524 (0.7%) 241 (0.7%)
Number of Hospitalizations for Other Reasons, 1+ 25,038 (11.1%) 4,055 (11.3%) 8,511 (11.8%) 4,055 (11.3%)
Colorectal Cancer 563 (0.2%) 90 (0.2%) 213 (0.3%) 90 (0.2%)
Prostate Cancer 636 (0.3%) 101 (0.3%) 224 (0.3%) 101 (0.3%)
Other Malignant Neoplasm Cancer 7,842 (3.5%) 1,555 (4.3%) 3,325 (4.6%) 1,555 (4.3%)
Congestive Heart Failure 2,477 (1.1%) 449 (1.2%) 938 (1.3%) 449 (1.2%)
Arthritis 2,110 (0.9%) 576 (1.6%) 1,143 (1.6%) 576 (1.6%)
Cerebrovascular Disease 4,777 (2.1%) 875 (2.4%) 1,838 (2.6%) 875 (2.4%)
Cluster Headaches/Migraines 10,188 (4.5%) 2,256 (6.3%) 4,642 (6.4%) 2,256 (6.3%)
Diabetes 17,361 (7.7%) 3,235 (9.0%) 6,737 (9.4%) 3,235 (9.0%)
Disorders of the Eye 285 (0.1%) 49 (0.1%) 105 (0.1%) 49 (0.1%)
Gait or Balance Disorder 2,426 (1.1%) 522 (1.4%) 1,065 (1.5%) 522 (1.4%)
Hyperparathyroidism 325 (0.1%) 80 (0.2%) 159 (0.2%) 80 (0.2%)
Osteoarthritis 14,325 (6.3%) 3,217 (8.9%) 6,528 (9.1%) 3,217 (8.9%)
Osteoporosis 3,776 (1.7%) 863 (2.4%) 1,758 (2.4%) 863 (2.4%)
Parkinson’s Disease 231 (0.1%) 36 (0.1%) 72 (0.1%) 36 (0.1%)
Seizures 1,641 (0.7%) 302 (0.8%) 686 (1.0%) 302 (0.8%)
Urinary Incontinence 2,421 (1.1%) 547 (1.5%) 1,152 (1.6%) 547 (1.5%)